Skip to content

Waiting on Atrial fibrillation Intervention Therapy (WAIT) Study

Status
Not yet recruiting
Phases
Phase 4
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2025-524182-25-00
Enrollment
200
Registered
2025-12-17
Start date
Unknown
Completion date
Unknown
Last updated
2025-12-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial fibrillation

Brief summary

Primary variable: Freedom from atrial fibrillation, atrial flutter, or atrial tachycardia lasting ≥30 seconds as detected by continuous monitoring via implantable loop recorder at 12 months post-ablation. Events within the initial 3-month blanking period will not be included.

Interventions

Sponsors

Karolinska University Hospital
Lead SponsorOTHER

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Design outcomes

Primary

MeasureTime frame
Primary variable: Freedom from atrial fibrillation, atrial flutter, or atrial tachycardia lasting ≥30 seconds as detected by continuous monitoring via implantable loop recorder at 12 months post-ablation. Events within the initial 3-month blanking period will not be included.

Countries

Sweden

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026